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Abstract— Background: Takayasu’s arteritis is a chronic 
vasculitis of unknown etiology affecting large vessels. Coronary 
involvement is rare and myocardial infarction as a presenting 
symptom has only been described in case reports. 
Case:  
We report a case of a 19 year old female diagnosed with 
Takayasu’s arteritis 2 years prior who came in due to chest pain 
and heart failure symptoms. ECG showed diffuse ischemia with 
ST elevation of the inferior wall. Coronary angiogram showed 3 
vessel disease with left main involvement. Patient was started on 
high dose steroids. She then developed an acute stroke in the right 
posterior cerebral artery territory. She improved with 
Methylprednisolone pulse therapy and oral methotrexate. She 
was discharged on Prednisone, Methotrexate and cardiac 
medications and is stable on follow up. 
Diagnostics: 
Coronary angiogram showed ostioproximal stenosis of the distal 
left main segment, the proximal left anterior descending artery 
and the proximal left circumflex artery, with the right coronary 
artery being totally occluded. Two dimensional echocardiogram 
showed an ejection fraction of 38 percent with multisegmental 
wall motion abnormalities. CT aortogram showed segmental 
narrowing of the infrarenal abdominal aorta with multiple 
ostioproximal stenosis of several aortic branches with extensive 
collateral formation. MRI showed acute infarction in the right 
thalamus,right medial temporal and occipital lobes and right 
cerebellar hemisphere and vermis 
Conclusion: Takayasu’s arteritis can present with a myriad of 
vascular complications. The reported incidence of coronary 
involvement is low. This case highlights the progressive and 
unpredictable nature of this disease. A high index of clinical 
suspicion, as well as a meticulous search for the extent of disease 
severity allows the clinician to individualize treatment options for 
these patients. 
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I.  INTRODUCTION  
Takayasu’s arteritis is a granulomatous inflammation of 
the large vessels that mainly affects the aorta and its major 
branches. It was named after Dr. Mikito Takayasu, a Japanese 
ophthalmologist who described it in 1908 as a clinical 
syndrome characterized by eye complications[1] and 
accentuated pulse weakness, hence it is also referred to 
classically as pulseless disease. Although its etiology and 
pathogenesis are unknown, an autoimmune mechanism is 
postulated2. Its presentation may vary depending on the extent 
of vascular involvement. Cases presenting as acute myocardial 
infarction are rare. We report a patient with Takayasu’s 
arteritis who presented with acute coronary syndrome. 
Workup revealed the extent of her disease and she developed 
an acute ischemic stroke during her hospital stay. 
 
II. CASE PRESENTATION 
A 19 year old female came into our institution with a chief 
complaint of severe sudden onset chest pain of a few hours 
duration. She has likewise been experiencing exertional 
dyspnea,orthopnea and paroxysmal nocturnal dyspnea since 3 
months prior. She was reportedly diagnosed with Takayasu’s 
arteritis 2 years prior but was lost to follow up. 
On physical examination the patient was conscious and 
coherent. Blood pressure at the right upper extremity was 
100/70 mmHg, 110/70 at the left upper extremity and 130/90 
on both lower extremities derived via Doppler measurements. 
Heart rate was regular at 72, respiratory rate was 22 cycles per 
minute and she was afebrile. She had a body mass index of 
18.7 kg/m2. There was note of bilateral carotid bruits. 
Cardiovascular examination revealed a soft s1 with a 2/6  
holosystolic murmur at the apex. Pulses were not appreciated 
on the right upper extremity and weak on the left upper 
extremity. 
On admission, ECG showed inferior wall ST elevation 
myocardial infarction and Troponin I was positive at 
0.461ng/ml. C reactive protein was elevated slightly at 
20.2mg/L. Creatinine and electrolytes were normal. Chest 
radiograph showed cardiomegaly with pulmonary congestion. 
She then had an episode of ventricular fibrillation and was 
defibrillated. Referral to Invasive Cardiology was done. 
Coronary angiogram showed 3 vessel disease with left main 
involvement (Figure 1).  She was started on Heparin drip and 
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referred to Thoracic and Cardiovascular Surgery, 
Rheumatology and Vascular Services. Hydrocortisone 
100mg/IV every 12 hours was started. Two dimensional 
echocardiogram showed an ejection fraction of 38% with 
concentric left ventricular hypertrophy with multisegmental 
wall motion abnormality indicative of coronary artery disease 
with depressed systolic function and grade III diastolic 
dysfunction with severe mitral regurgitation. Carotid Duplex 
Scan showed >50% stenosis of the left internal carotid 
artery(ICA) and total occlusion of the right common carotid 
artery. Vertebral arteries were totally occluded bilaterally. 
(Figure 2) CT Aortogram showed segmental narrowing of the 
infrarenal abdominal aorta and multiple ostioproximal 
stenosis, with almost total occlusion of the proximal left 
subclavian artery, and total occlusion of the proximal superior 
mesenteric artery. There was also a 70-80% stenosis of the 
proximal right renal artery and almost total occlusion of the 
ostium of the left renal artery. (Figure 3) The patient improved 
clinically with resolution of the previously noted ST segment 
elevation. The plan was to do Off pump coronary artery bypass 
(OPCAB). However she developed left sided weakness, 
dizziness and slurring of speech on her 7th hospital day. Cranial 
magnetic resonance imaging (Figure 4) showed acute 
infarction of the right thalamus, right medial temporal and 
occipital lobes and right cerebellar hemisphere and vermis. 
Patient was then brought to the Medical ICU for closer 
monitoring. She was started on Methylprednisolone pulse 
therapy for three days. There was noted improvement of the 
patient’s neurologic symptoms. Medications were continued 
including Prednisone 40mg/day and Methotrexate 10mg once 
a week. She was cleared for discharge and was stable on follow 
up.  
 
III. DIAGNOSTICS 
 
 
Figure 1 
Figure 1 showed a good sized left main artery with 80% 
concentric stenosis at the distal segment (left,arrow) The left 
anterior descending artery showed a 90% ostioproximal 
stenosis with TIMI 3 flow with haziness of the proximal 
segment suggestive of thrombus.  The left circumflex artery is 
co-dominant and also has a 80% ostioproximal stenosis 
(middle,arrows) The right coronary artery is totally 
occluded(right,arrow)  
 
Figure 2 
Figure 2: Carotid doppler study shows near total occlusion 
to total occlusion of the right common carotid artery (left), 
proximal left internal carotid artery shows increased peak 
systolic velocities indicating either compensatory flow or 
significant (>50%) stenosis of the left internal carotid artery 
(center).  Both vertebral arteries appear totally occluded 
(right,left vertebral artery shown) 
 
 
Figure 3 
Figure 3 CT Aortogram with volume rendering 
technique reveals stenotic lesions in the major branches of the 
aortic arch, celiac and superior mesenteric arteries, bilateral 
renal arteries and bilateral iliac arteries. 
 
 
Figure 4 
 
Figure 4 Cranial MRI diffusion weighted imaging shows 
acute infarction corresponding to the arterial territory of the 
right posterior circulation (left and middle) Cranial MRA 
maximum intensity projection shows absence of flow in the 
brachiocephalic and left subclavian arteries with  severe 
diminution of flow in the right carotid and the vertebrobasilar 
system (right) 
 
 
GSTF Journal of Advances in Medical Research (JAMR) Vol.1 No.3, October 2015
©The Author(s) 2015. This article is published with open access by the GSTF
2
IV. DISCUSSION 
Takayasu’s arteritis is a chronic inflammatory disease of 
unknown cause. It has worldwide distribution but is more 
common in Asia most notably Japan, India and China [2]. It 
has an estimated incidence of 2.6/100,000,0/year with a female 
to male ratio of 2-3:1. [3] The disease onset is insidious, 
presenting initially with nonspecific and constitutional signs 
and symptoms (pre vasculitic phase) and progressing to 
involve branches of the aorta. This phase (vasculitic or 
pulseless phase) is characterized by diminished or absent 
pulses, hypertension, claudication and neurological 
involvement as well as other forms of vascular insufficiency. 
This may or may not be accompanied by flares. Aortic 
insufficiency, heart failure and stroke as well as renal artery 
stenosis have been described in literature. [4]  The third stage 
is the burned-out stage, when fibrosis sets in, and generally is 
associated with remission. 
The first classification and natural history of Takayasu's 
arteritis was reported by Ishikawa in 1985, which he based on 
the severity of involvement and the presence of 
complications.[5] In 1990 the American College of 
Rheumatology established the criteria for classification of 
disease based on age of diagnosis of <40 years old and the 
presence of the following: presence of claudication, decreased 
brachial artery pulse, blood pressure difference >10mmHg, 
bruit over subclavian arteries and arteriogram abnormality. [6] 
This classification was then revised by Sharma et al[7] 
removing the age of onset of <40 years old, including 
characteristic signs and symptoms and coronary artery 
involvement.  
After recognition of specific signs and symptoms, 
elevation of acute phase reactants have been proposed to 
determine the presence of active disease. While widely used, 
these are non specific measures and had low sensitivity and 
specificity in reflecting disease flares. Our patient only had a 
modest elevation of C reactive protein (CRP) which eventually 
normalized. Based on the NIH criteria, the presence of 
symptoms and elevation of acute phase reactants as well as 
evidence of findings on imaging are indicative of active 
disease. [8] Other measures to determine disease activity such 
as Matrix Metalloproteinases or Pentraxin have been studied 
and were found superior to both erythrocyte sedimentation rate 
and CRP. [9] 
Imaging studies complement the clinical and laboratory 
evaluation. While arteriography is classically considered the 
gold standard to visualize the extent of arterial involvement, 
other imaging modalities may be used. Doppler ultrasound is 
non invasive and can identify occlusive changes and measure 
post stenotic velocity. CT angiography and magnetic 
resonance imaging and angiography can identify occlusive 
lesions with very good specificity and sensitivity. Imaging 
studies facilitate early diagnosis and provide assessment of 
disease extent, inflammatory activity and response to 
treatment. [10] Mason reported a comparison of different 
imaging modalities and concluded that no single modality 
provides all the information required and that each may have 
complimentary roles. [11] 
The incidence of coronary artery involvement has been 
reported to be 9% to 10%, and is observed mainly in autopsy 
cases. Coronary artery disease is usually not evident until the 
occurrence of angina pectoris or myocardial infarction, or after 
the onset of congestive heart failure. Based on the report by 
Masubara et al, [12] the following three types of coronary 
artery lesions can be distinguished: type 1, stenosis or 
occlusion of the coronary ostia and the proximal segments of 
the coronary arteries.Type 2, diffuse or focal coronary arteritis, 
which may extend diffusely to all epicardial branches or may 
involve focal segments, so-called skip lesions; and type 3, 
coronary aneurysm. Type 1 occurs in 2/3 of patients as was the 
case in our patient Nasu reported a 10.5% rate of coronary 
lesions that complicated Takayasu's arteritis.[13] Patients have  
predisposition to inflammation and atherosclerosis. Coronary 
ostial stenosis occurs as a result of the extension of 
inflammation, which induces intimal proliferation and fibrous 
contraction in the ascending aorta around the coronary 
ostia.[14] Inflammation may involve the entire epicardial tree. 
Our patient presented with angina pectoris which is an unusual 
presentation, reported in about 6-16% of cases. Myocarditis, 
pericarditis and cardiomyopathy have also been reported.[15] 
Interventional treatment for our patient is problematic. 
There have been reports of successful stent placement for renal 
artery stenosis and subclavian stenosis, the results of which 
require additional follow up. [16;17] Percutaneous catheter 
intervention of the coronary arteries have been done but was 
associated with a high frequency of re-stenosis [18]. Drug 
eluting stents may have potential benefit. [19] 
Surgical options are coronary artery bypass graft, surgical 
angioplasty of the left main coronary artery, and transaortic 
coronary ostial endarterectomy [20]. The timing of the 
operation is important, and surgical treatment should generally 
be avoided during the active inflammatory stage of disease. 
With the patient being a high risk patient our initial plan for 
the patient was to undergo off pump coronary artery bypass 
graft (OPCAB). It was initially postulated that the use of 
saphenous vein grafts may be more beneficial in these patients 
due to a high restenosis rate for arterial grafts.[21] However 
Kwon Joong et al reported very good outcomes with OPCAB 
as well as use of in situ arterial grafts[22]. 
Both medical and surgical modalities play an important 
role in the management of Takayasu’s arteritis. Our patient 
experienced a stroke during her hospital stay prior to the 
planned surgery. Patient also has bilateral renal artery stenosis. 
Renal function and urine output were maintained due to the 
extensive collateralization. With all these high risk features we 
decided to treat our patient with optimal medical management. 
While steroids are the mainstay of treatment, newer 
immunosuppressant medications have shown promise such as 
immunosuppressants and cytotoxic agents. Prednisone is 
usually prescribed followed by a slow taper. This therapy 
allows for 67% remission, but up to 50% treated individuals 
will relapse. Relapses are treated with either increasing 
corticosteroid dose or the addition of a corticosteroid sparing 
immunosuppressant such as methotrexate as well as other 
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immunosuppressive drugs. [23] 
The prognosis for our patient is generally poor. According 
to the Ishikawa classification, the presence of major 
complications such as heart failure, acute MI and a progressive 
course showed the worst prognosis of only 43% survival at 15 
years [24]. Another study by Park et al showed a 10 year 
survival rate of 87.2 %, with the presence of more than two 
complications rendering a 66.9% survival at 5 years and a 
36.7% at 10 years respectively. Independent prognostic factors 
were low ESR, treatment with steroids and stable disease 
activity.[25] 
There have been reports of Takayasu arteritis with global 
arterial involvement involving the coronary arteries. [26] To 
our knowledge this is the first report of a patient presenting 
with myocardial infarction and complicated by stroke. 
Wheeler et al reported a case of a vasculitis presenting with 
myocardial infarction, stroke and aortitis[27]. It was not 
specified whether the patient had Takayasu’s arteritis or giant 
cell arteritis. In our patient this was also accompanied by 
bilateral renal artery stenosis and heart failure attributable to 
left ventricular dysfunction. There was no aortic insufficiency 
noted. The presence of many vascular complications and 
active disease flare precluded us from pushing through with 
our surgical plans. There have been reports of successful 
angiographic regression of atherosclerosis in patients with 
maximal medical therapy alone[28;29;30].This patient 
warrants close and continuous monitoring with imaging 
studies at least every 3-6 months as well as compliance to 
medications. [31]. 
 
V. CONCLUSION 
Takayasu’s arteritis is a chronic and granulomatous 
vasculitis of the large elastic arteries that presents as a 
combination of vaso-occlusive disease and systemic 
inflammation. While coronary involvement is rare its 
inflammatory pathophysiology implies that any vascular 
complication is possible. It still remains both a diagnostic and 
therapeutic challenge. This case highlights the enigmatic and 
progressive nature of Takayasu’s arteritis and the need for 
vigilance in its diagnosis and monitoring. Treatment is 
individualized incorporating both effective 
immunosuppressive therapy and timely surgical management. 
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